NIAGEN BIOSCIENCE, INC. Increase (Decrease) in Contract with Customer, Asset
NIAGEN BIOSCIENCE, INC. (NAGE) reported Increase (Decrease) in Contract with Customer, Asset of $0 for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2020-08-06
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, asset for the quarter ending 2020-06-30 was $0.00.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, asset for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, asset for the quarter ending 2019-12-31 was $89.00K, a 323.81% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, asset for the quarter ending 2019-09-30 was -$37.00K.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, asset for fiscal 2019 was $56.00K.
- NIAGEN BIOSCIENCE, INC. increase (decrease) in contract with customer, asset for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 3 month as first filed | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $89.00K derived: sum of 3 quarters · filed 2020-08-06 | $52.00K derived: sum of 4 quarters · filed 2020-08-06 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-18 | $89.00K derived: sum of 2 quarters · filed 2020-05-18 | $52.00K derived: sum of 3 quarters · filed 2020-05-18 | $40.00K derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $52.00K derived: sum of 2 quarters · filed 2020-03-10 | $40.00K derived: sum of 3 quarters · filed 2020-08-06 | $56.00K 10-K · filed 2020-03-10 | |
| 2019-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$49.00K derived: sum of 2 quarters · filed 2020-08-06 | -$33.00K 10-Q · filed 2019-11-12 | -$12.00K derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.00K 10-Q · filed 2020-08-06 | $25.00K derived: sum of 3 quarters · filed 2020-08-06 | $11.00K derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $16.00K 10-Q · filed 2020-05-18 | -$16.00K 10-Q · filed 2019-05-09 | $37.00K derived: sum of 2 quarters · filed 2020-05-18 | $23.00K derived: sum of 3 quarters · filed 2020-05-18 | $13.00K derived: sum of 4 quarters · filed 2020-05-18 |
| 2018-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $7.00K derived: sum of 2 quarters · filed 2020-03-10 | -$3.00K derived: sum of 3 quarters · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 | |
| 2018-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$24.00K derived: sum of 2 quarters · filed 2019-11-12 | -$21.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$7.00K 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | $3.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |